| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |